Is the safety of contrast agents an issue in body computed tomography?
- PMID: 8282506
- DOI: 10.1097/00004424-199311001-00021
Is the safety of contrast agents an issue in body computed tomography?
Abstract
Rationale and objectives: To investigate the comparative safety profiles of nonionic and ionic contrast agents in body computed tomography (CT) studies.
Methods: A literature search was conducted to examine the following variables: image quality, repeat or aborted studies, and the cost of nonionic agents versus benefits. Data are presented that address the following questions: Does administering nonionic agents save time? Are nonionic agents more likely to provide an adequate study? Does an adequate study necessarily ensure an improved detection rate?
Results: The administration of nonionic contrast does not save time during the body CT studies. There is little significant difference between the sensitivity for making a diagnosis when using an ionic or nonionic agent.
Conclusion: The lack of difference in diagnostic sensitivity or time to perform a study between ionic and nonionic agents does not warrant the conversion to nonionic agents in body CT.
Similar articles
-
Comparison of iohexol 300 and diatrizoate meglumine 60 for body CT: image quality, adverse reactions, and aborted/repeated examinations.AJR Am J Roentgenol. 1992 Mar;158(3):665-7. doi: 10.2214/ajr.158.3.1739017. AJR Am J Roentgenol. 1992. PMID: 1739017 Clinical Trial.
-
The comparative effects of ionic versus nonionic agents in cardiac catheterization.Invest Radiol. 1988 Nov;23 Suppl 2:S366-73. doi: 10.1097/00004424-198811002-00010. Invest Radiol. 1988. PMID: 3058641 Review.
-
Prospective randomized trial of iohexol 350 versus meglumine sodium diatrizoate as an oral contrast agent for abdominopelvic computed tomography.J Comput Assist Tomogr. 2011 Mar-Apr;35(2):202-5. doi: 10.1097/RCT.0b013e3182058e76. J Comput Assist Tomogr. 2011. PMID: 21412090 Clinical Trial.
-
Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The Iohexol Cooperative Study.Am J Cardiol. 1993 Oct 1;72(11):770-5. doi: 10.1016/0002-9149(93)91061-l. Am J Cardiol. 1993. PMID: 8213508 Clinical Trial.
-
The clotting issue: etiologic factors in thromboembolism. II. Clinical considerations.Invest Radiol. 1993 Nov;28 Suppl 5:S31-6; discussion S37-8. Invest Radiol. 1993. PMID: 8282500 Review.